Efficacy and safety of add-on anti-CD20 monoclonal antibody to Bruton tyrosine kinase inhibitor treatment for chronic lymphocytic leukemia: a meta-analysis. [PDF]
Nguyen TT +7 more
europepmc +1 more source
Clinical and Translational Science, Volume 19, Issue 11, November 2026.
Paridhi Gupta +3 more
wiley +1 more source
Remibrutinib as a Therapeutic Option for Solar Urticaria
Photodermatology, Photoimmunology &Photomedicine, Volume 42, Issue 6, November 2026.
Joshua Mijares +3 more
wiley +1 more source
Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review. [PDF]
Kiyani M, Clanahan O, Silverman MA.
europepmc +1 more source
Invasive fungal infections after Bruton tyrosine kinase inhibitor treatment: a systematic review and meta-analysis. [PDF]
Srisurapanont K +10 more
europepmc +1 more source
Efficacy and Safety of Bruton Tyrosine Kinase Inhibitor Monotherapy Compared with Combination Therapy for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis. [PDF]
Nguyen TT +4 more
europepmc +1 more source
Bruton Tyrosine Kinase Inhibitor Ibrutinib and Pericardial Tamponade: A Case Report. [PDF]
Baptista M +4 more
europepmc +1 more source

